Our Mission:


Develop and commercialize new technologies to improve outcomes from Traumatic Brain Injury (TBI).















Archeoptix received Health Canada approval for the NIRD™-HD on February 22, 2016.


The brain is complex - trying to measure how a brain functions is very difficult, requiring guesswork and interpretation of data.


Alcohol, drugs, and pre-existing mental conditions can mimic the symptoms of a TBI when monitoring and interpreting brain function.


The ArcheOptix technologies measure and image structures to determine the severity of TBI - structures that should NOT be present in a normal, healthy brain.


These structural abnormalities are either present or they are not.  When they are present, the NIRD™ series of devices will see them.




Traumatic Brain Injury has come to be known as the 'Silent Epidemic'.






See What We Are Doing >